Xgenera
Paul Skipp is a seasoned professional with extensive experience in the fields of biological and biomedical sciences. Currently serving as Director, CSO, and Founder at Xgenera since June 2023, Paul also holds the position of Director and Co-Founder at TopMD Precision Medicine Ltd, a role maintained since 2018. Additionally, Paul has been a Professor and Centre Director at the Centre for Proteomic Research at the University of Southampton since 1990. Paul earned a Doctor of Philosophy (PhD) in Biological and Biomedical Sciences from the University of Southampton.
This person is not in any teams
Xgenera
Xgenera is dedicated to transforming cancer diagnosis through their groundbreaking multi-cancer early detection (MCED) test. With a mission to save lives by identifying cancer at its earliest stages, Xgenera leverages cutting-edge technology and advanced algorithms to detect a wide range of cancers with exceptional accuracy. By detecting cancer earlier, when treatment options are most effective, Xgenera aims to improve patient outcomes and ultimately reduce the global burden of cancer. Backed by data from large patient cohorts and ongoing research, Xgenera's MCED test holds the potential to revolutionise cancer diagnosis around the world. With a commitment to empowering individuals and healthcare providers with timely, actionable information, Xgenera is at the forefront of the fight against cancer, paving the way for a future where early detection saves lives.